Thermal degradation of injectable epinephrine

Area of Science:

• Pharmaceutical Chemistry
• Drug Stability Studies

Background:

• Epinephrine (EPI) is a critical drug for treating anaphylaxis and cardiac arrest.
• Its stability in injectable formulations is crucial for efficacy and patient safety.
• Understanding degradation pathways under stress conditions is essential for product development and storage guidelines.

Purpose of the Study:

• To investigate the degradation kinetics of epinephrine (EPI) in USP injectable solutions.
• To determine the impact of different heating conditions (cyclical vs. constant) on EPI and EPI sulfonic acid (EPI-SA) formation.
• To explore the role of sodium metabisulfite concentration in EPI degradation.

Main Methods:

• Epinephrine injectable solutions (1:10,000) were subjected to cyclical (65°C, 8 hr/d, 4-12 weeks) and constant (65°C, 7 days) heating.
• High-performance liquid chromatography (HPLC) with diode array and electrochemical detection was used to quantify EPI and EPI-SA levels.
• Laboratory-prepared solutions were used to assess the influence of sodium metabisulfite concentration and heating duration.

Main Results:

• Constant heating (169 total hours) led to complete degradation of EPI and EPI-SA, with significant dark brown discoloration.
• Cyclical heating (672 total hours) resulted in a 31% EPI reduction and a 225% EPI-SA increase, without discoloration.
• EPI degradation and EPI-SA formation were dependent on sodium metabisulfite concentration and cyclical heating duration.

Conclusions:

• The thermal stability of epinephrine is highly dependent on the method and duration of heat exposure.
• Constant heating poses a significant risk to epinephrine stability, leading to complete degradation and discoloration.
• Cyclical heating also degrades epinephrine, but the presence and concentration of sodium metabisulfite play a critical role in modulating this degradation process.